Gastrointestinal infection with Aeromonas: incidence and relationship to inflammatory bowel disease

Ainara Elorza1, Iago Rodríguez-Lago2, Patricia Martínez3

  • 1Servicio de Aparato Digestivo, Hospital Galdakao-Usansolo, Galdakao, España.

Gastroenterologia Y Hepatologia
|July 26, 2020
PubMed
Abstract

Insights

Aeromonas gastrointestinal infections are common, affecting both healthy and immunocompromised individuals. Comorbidity is a significant risk factor, especially in those without inflammatory bowel disease.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Aeromonas bacteria are known causes of human diseases, primarily gastroenteritis.
  • Recent research has questioned the role of Aeromonas in causing human enterocolitis.

Purpose of the Study:

  • To investigate the incidence of Aeromonas gastrointestinal infections in a specific region.
  • To explore the potential association between Aeromonas infection and inflammatory bowel disease (IBD).

Main Methods:

  • A retrospective observational study was conducted.
  • Adult patients with positive stool cultures for Aeromonas were identified from January 2015 to December 2017.
  • Data were collected from Hospital Galdakao-Usansolo in Vizcaya, Spain.

Main Results:

  • The incidence of Aeromonas infection was determined to be 32 cases per 10^5 inhabitants annually.
  • Eleven percent of infected patients had a prior diagnosis of inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease.
  • Comorbidity was identified as the primary risk factor for Aeromonas infection, particularly in patients without IBD, while immunosuppressive therapy was more common in IBD patients.

Conclusions:

  • Aeromonas infection represents a frequent gastrointestinal illness.
  • Both immunocompetent and immunocompromised individuals can be affected.
  • While immunosuppression is a key factor for IBD patients, comorbidity presents a higher risk for non-IBD patients.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
727
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
787
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
542
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
806
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
991
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
675